Patents by Inventor Eri Harada

Eri Harada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12545062
    Abstract: A tire management device (10) includes: an information acquisition section (131) that acquires mounted position information indicating a mounted position of a tire on a vehicle (20) and mounted tire information that is information on the state of the tire including internal pressure; a determination section (132) that determines an abnormal internal pressure of the tire based on the mounted tire information; and a notification section (133) that outputs the mounted position and an abnormal internal pressure determination result of the tire that has been determined to have an abnormal internal pressure to a notification destination.
    Type: Grant
    Filed: June 1, 2022
    Date of Patent: February 10, 2026
    Assignee: BRIDGESTONE CORPORATION
    Inventors: Shuzo Yanagida, Daisuke Sato, Hiroki Yasuda, Takanori Karube, Shunsuke Sentoku, Tomoaki Miyoshi, Eri Harada
  • Patent number: 12516294
    Abstract: Mesenchymal stem cells may be efficiently obtained from a biological cell sample containing mesenchymal stem cells by: (1) culturing the biological cell sample containing mesenchymal stem cells in a serum-free medium in the presence of vitronectin or a partial peptide thereof capable of adhering mesenchymal stem cells, and (2) collecting a cell aggregate of the mesenchymal stem cells.
    Type: Grant
    Filed: February 25, 2022
    Date of Patent: January 6, 2026
    Assignee: AJINOMOTO CO., INC.
    Inventors: Ikue Harata, Eri Harada, Kazuma Takahashi, Fumie Honkawa
  • Publication number: 20250128549
    Abstract: A tire management device (10) includes: an information acquisition section (131) that acquires mounted position information indicating a mounted position of a tire on a vehicle (20) and mounted tire information that is information on the state of the tire including internal pressure; a determination section (132) that determines an abnormal internal pressure of the tire based on the mounted tire information; and a notification section (133) that outputs the mounted position and an abnormal internal pressure determination result of the tire that has been determined to have an abnormal internal pressure to a notification destination.
    Type: Application
    Filed: June 1, 2022
    Publication date: April 24, 2025
    Applicant: BRIDGESTONE CORPORATION
    Inventors: Shuzo YANAGIDA, Daisuke SATO, Hiroki YASUDA, Takanori KARUBE, Shunsuke SENTOKU, Tomoaki MIYOSHI, Eri HARADA
  • Publication number: 20220177848
    Abstract: Mesenchymal stem cells may be efficiently obtained from a biological cell sample containing mesenchymal stem cells by: (1) culturing the biological cell sample containing mesenchymal stem cells in a serum-free medium in the presence of vitronectin or a partial peptide thereof capable of adhering mesenchymal stem cells, and (2) collecting a cell aggregate of the mesenchymal stem cells.
    Type: Application
    Filed: February 25, 2022
    Publication date: June 9, 2022
    Applicant: AJINOMOTO CO., INC.
    Inventors: Ikue HARATA, Eri HARADA, Kazuma TAKAHASHI, Fumie HONKAWA
  • Publication number: 20120088737
    Abstract: The present invention provides a pharmaceutical which possesses an excellent inhibitory effect on NHE3 (Na+/H+ exchanger type 3) and effectively improves diseases or conditions of organs in which NHE3 is expressed.
    Type: Application
    Filed: October 1, 2010
    Publication date: April 12, 2012
    Applicant: AJINOMOTO CO., INC
    Inventors: Wataru MIYANAGA, Yoichiro SHIMA, Misato NOGUCHI, Akiko OONUKI, Yayoi KAWATO, Hiroshi IWATA, Eri HARADA, Ryuta TAKASHITA, Hirokazu UENO, Tadakiyo NAKAGAWA
  • Publication number: 20110082109
    Abstract: The present invention provides a pharmaceutical which possesses an excellent inhibitory effect on NHE3 (Na+/H+ exchanger type 3) and effectively improves diseases or conditions of organs in which NHE3 is expressed.
    Type: Application
    Filed: October 1, 2010
    Publication date: April 7, 2011
    Applicant: AJINOMOTO CO., INC.
    Inventors: Wataru MIYANAGA, Yoichiro Shima, Misato Noguchi, Akiko Oonuki, Yayoi Kawato, Hiroshi Iwata, Eri Harada, Ryuta Takashita, Hirokazu Ueno, Tadakiyo Nakagawa